List of Metabolex patents

Patents where

Current Assignee

Name

‌

Metabolex

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7622491 Modulators of PPAR and methods of their preparation	Patent 7622491 was granted and assigned to Metabolex on November, 2009 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7622491	November 24, 2009
‌ US Patent RE40624 Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)	Patent RE40624 was granted and assigned to Metabolex on January, 2009 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	RE40624	January 20, 2009
‌ US Patent 8476308 GPR120 receptor agonists and uses thereof	Patent 8476308 was granted and assigned to Metabolex on July, 2013 by the United States Patent and Trademark Office.	‌ Metabolex	‌ Metabolex	United States Patent and Trademark Office	8476308	July 2, 2013
‌ US Patent 7510851 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia	Patent 7510851 was granted and assigned to Metabolex on March, 2009 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7510851	March 31, 2009
‌ US Patent 7638541 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine	Patent 7638541 was granted and assigned to Metabolex on December, 2009 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7638541	December 29, 2009
‌ US Patent 8227495 2,4-disubsituted thiazoles and pharmaceutical compositions thereof	Patent 8227495 was granted and assigned to Metabolex on July, 2012 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	8227495	July 24, 2012
‌ US Patent 7491533 Polynucleotides encoding an isolated β-islet cell two-pore domain potassium channel	Patent 7491533 was granted and assigned to Metabolex on February, 2009 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7491533	February 17, 2009
‌ US Patent 8183381 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders	Patent 8183381 was granted and assigned to Metabolex on May, 2012 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	8183381	May 22, 2012
‌ US Patent 7199259 Resolution of α-(phenoxy)phenylacetic acid derivatives	Patent 7199259 was granted and assigned to Metabolex on April, 2007 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7199259	April 3, 2007
‌ US Patent 7405289 Pancreatic islet transcription factor and uses thereof	Patent 7405289 was granted and assigned to Metabolex on July, 2008 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7405289	July 29, 2008
‌ US Patent 7556930 CD39L3 and its role in diabetes	Patent 7556930 was granted and assigned to Metabolex on July, 2009 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7556930	July 7, 2009
‌ US Patent 8410127 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts	Patent 8410127 was granted and assigned to Metabolex on April, 2013 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	8410127	April 2, 2013
‌ US Patent 7642358 Substituted phenylacetic acids	Patent 7642358 was granted and assigned to Metabolex on January, 2010 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7642358	January 5, 2010
‌ US Patent 7714131 Process for the stereoselective preparation of (−)-halofenate and derivatives thereof	Patent 7714131 was granted and assigned to Metabolex on May, 2010 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7714131	May 11, 2010
‌ US Patent 7294698 Methods and reagents for diagnosis and treatment of diabetes	Patent 7294698 was granted and assigned to Metabolex on November, 2007 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7294698	November 13, 2007
‌ US Patent 8481597 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia	Patent 8481597 was granted and assigned to Metabolex on July, 2013 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	8481597	July 9, 2013
‌ US Patent 7323480 Substituted triazoles as modulators of PPAR and methods of their preparation	Patent 7323480 was granted and assigned to Metabolex on January, 2008 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7323480	January 29, 2008
‌ US Patent 8598374 GPR120 receptor agonists and uses thereof	Patent 8598374 was granted and assigned to Metabolex on December, 2013 by the United States Patent and Trademark Office.	‌ Metabolex	‌ Metabolex	United States Patent and Trademark Office	8598374	December 3, 2013
‌ US Patent 7432394 Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines	Patent 7432394 was granted and assigned to Metabolex on October, 2008 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7432394	October 7, 2008
‌ US Patent 7109021 Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)	Patent 7109021 was granted and assigned to Metabolex on September, 2006 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7109021	September 19, 2006
‌ US Patent 7371888 α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents	Patent 7371888 was granted and assigned to Metabolex on May, 2008 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7371888	May 13, 2008
‌ US Patent 7344844 Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)	Patent 7344844 was granted and assigned to Metabolex on March, 2008 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7344844	March 18, 2008
‌ US Patent 7144985 Methods and reagents for diagnosis and treatment of diabetes	Patent 7144985 was granted and assigned to Metabolex on December, 2006 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7144985	December 5, 2006
‌ US Patent 7087394 Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP	Patent 7087394 was granted and assigned to Metabolex on August, 2006 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	7087394	August 8, 2006
‌ US Patent 8354448 Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes	Patent 8354448 was granted and assigned to Metabolex on January, 2013 by the United States Patent and Trademark Office.		‌ Metabolex	United States Patent and Trademark Office	8354448	January 15, 2013

Results per page:

33 results

0 selected

33 results

0 selected